Softwr

Healthcare · head to head

PathAI vs Thermo SampleManager LIMS

PathAI logo

PathAI

Healthcare

Digital pathology image management with an FDA cleared platform for primary diagnosis

From
On request
Rated
-
Thermo SampleManager LIMS logo

Thermo SampleManager LIMS

Research

Enterprise LIMS for regulated QC laboratories, with LES and SDMS in one product

From
On request
Rated
-

The short version

  • Each has a real cost: PathAI aISight is labelled research use only and cannot be used for primary diagnosis; only AISight Dx carries the FDA clearance and CE-IVD mark, and laboratories regularly buy the wrong configuration and discover they cannot sign out on it.; Thermo SampleManager LIMS no pricing is published in any form, and Thermo Fisher routes even basic cost questions through a request for quote, so early stage budget planning is guesswork.
  • They diverge on capability: PathAI covers AISight image management, Thermo SampleManager LIMS covers Sample lifecycle management.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which PathAI and Thermo SampleManager LIMS actually diverge.

Attributes where PathAI and Thermo SampleManager LIMS differ
AttributePathAIThermo SampleManager LIMS
PlatformsWebWeb, Windows, Linux
CategoryHealthcareResearch

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in PathAI

  • AISight image management
  • AISight Dx
  • Scanner interoperability
  • Case and worklist management
  • AI algorithm deployment
  • Biopharmaceutical research tooling
  • LIS integration

Only in Thermo SampleManager LIMS

  • Sample lifecycle management
  • Specifications and OOS handling
  • Laboratory execution system
  • Scientific data management
  • Stability studies
  • Instrument management
  • Environmental monitoring

What people use each for

The jobs each tool is most often brought in to do.

PathAI

  • An academic medical centre going digital for primary diagnosis that needs the FDA cleared AISight Dx configuration rather than the research labelled versionnot Thermo SampleManager LIMS
  • A reference laboratory consolidating subspecialty sign out across sites so a specialist pathologist can read cases from any locationnot Thermo SampleManager LIMS
  • A pharmaceutical company needing consistent quantitative scoring of trial biopsies across many sites and readersnot Thermo SampleManager LIMS
  • A laboratory with a mixed scanner estate that needs one image management layer rather than each scanner vendor viewernot Thermo SampleManager LIMS

Thermo SampleManager LIMS

  • A pharmaceutical QC laboratory that needs enforced method execution and electronic signatures for GMP release testingnot PathAI
  • A multi site chemical or petrochemical business standardising sample handling and specifications across laboratoriesnot PathAI
  • A water or environmental testing laboratory with high sample throughput and regulatory reporting obligationsnot PathAI
  • A laboratory replacing a LIMS plus separate LES and SDMS estate and wanting to retire two integrations along with the old systemnot PathAI

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

PathAI

  • AISight is labelled research use only and cannot be used for primary diagnosis; only AISight Dx carries the FDA clearance and CE-IVD mark, and laboratories regularly buy the wrong configuration and discover they cannot sign out on it.
  • The software licence is usually the smallest line in a digital pathology project, behind scanners, storage and network capacity, so a business case built around the software cost understates the real investment by a wide margin.
  • Whole slide images are very large, so a laboratory that does not model storage growth and retention policy from the start faces storage costs that grow faster than case volume and dominate the renewal.
  • Clinical validation is required per subspecialty rather than once for the platform, which means dermatopathology, gastrointestinal and breast each need their own concordance study and pathologist time before go live.
  • PathAI competes against pathology incumbents that also sell the scanners, and a laboratory buying an independent image management layer takes on the integration risk between scanner vendor and software vendor itself.

Thermo SampleManager LIMS

  • No pricing is published in any form, and Thermo Fisher routes even basic cost questions through a request for quote, so early stage budget planning is guesswork.
  • Implementation is configuration heavy and normally requires Thermo Fisher professional services or a specialist partner, and services costs routinely exceed the licence cost in the first year.
  • Computer system validation is the customer responsibility on top of implementation, so a GMP laboratory carries a validation programme of its own before go live and repeats a subset of it at every upgrade.
  • Cloud hosting is charged as an annual fee scaled to licence count, so seats drive infrastructure cost as well as licence cost and occasional users are expensive twice.
  • The product carries a long codebase history and its configuration model is specialist, which makes in house administrators hard to recruit and creates a dependency on external consultants for changes that would be self service in a newer LIMS.

Pricing, plan by plan

PathAI

On request
  • AISight$undefined/year
    • Priced by annual slide or case volume and by pathologist seats
    • AISight Dx, the clinically cleared configuration, quoted separately from research use AISight
    • Image storage priced by capacity and retention policy

Thermo SampleManager LIMS

On request
  • SampleManager LIMS$undefined/year
    • Quoted through the Thermo Fisher sales team, nothing published
    • Annual hosting fee calculated on the number of licences for cloud deployments
    • Deployment as Thermo managed AWS, on premise, or customer cloud

Which should you pick?

Choose PathAI if

  • You need aisight image management.
  • You also want aisight dx.

Choose Thermo SampleManager LIMS if

  • You need sample lifecycle management.
  • You work on Web, Windows, Linux.
  • You also want specifications and oos handling.

Questions people ask

Is PathAI or Thermo SampleManager LIMS better?
Neither clearly leads. PathAI starts at On request and Thermo SampleManager LIMS at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, PathAI or Thermo SampleManager LIMS?
PathAI starts at On request and Thermo SampleManager LIMS at On request.
Does PathAI or Thermo SampleManager LIMS run on more platforms?
PathAI runs on Web. Thermo SampleManager LIMS runs on Web, Windows, Linux.
What is PathAI best used for?
PathAI is most often used for an academic medical centre going digital for primary diagnosis that needs the fda cleared aisight dx configuration rather than the research labelled version, a reference laboratory consolidating subspecialty sign out across sites so a specialist pathologist can read cases from any location, a pharmaceutical company needing consistent quantitative scoring of trial biopsies across many sites and readers, a laboratory with a mixed scanner estate that needs one image management layer rather than each scanner vendor viewer. Of those, an academic medical centre going digital for primary diagnosis that needs the fda cleared aisight dx configuration rather than the research labelled version and a reference laboratory consolidating subspecialty sign out across sites so a specialist pathologist can read cases from any location are not what Thermo SampleManager LIMS is typically brought in for.
What can PathAI do that Thermo SampleManager LIMS cannot?
PathAI covers AISight image management, AISight Dx, Scanner interoperability, Case and worklist management. Thermo SampleManager LIMS covers Sample lifecycle management, Specifications and OOS handling, Laboratory execution system, Scientific data management.

Answered from the vendors’ own pages

PathAI: What is the difference between AISight and AISight Dx?

AISight is for research use only and not for clinical diagnostic use. AISight Dx received FDA 510(k) clearance in June 2025 for primary diagnosis and is CE-IVD marked in the EEA, UK and Switzerland. Only the Dx configuration can be used to sign out cases.

Thermo SampleManager LIMS: Does SampleManager include LES and SDMS?

Yes. Laboratory execution and scientific data management are part of the product rather than separate purchases, which removes two integration projects.

PathAI: Can we use our existing scanners?

Yes. AISight is designed to ingest images from multiple whole slide scanner vendors, which is one of the main reasons laboratories choose an independent image management layer.

Thermo SampleManager LIMS: How much does it cost?

Nothing is published. Pricing is quoted, and cloud deployments carry an annual hosting fee based on licence count.

PathAI: Do the AI algorithms carry the same clearance as the platform?

No. The platform clearance covers image management for primary diagnosis. Individual algorithms have their own labelling, and many are research use only. Check each one separately.

Thermo SampleManager LIMS: Is it validated when I buy it?

Thermo Fisher supplies qualification documentation, but computer system validation of your configured instance remains your responsibility.

PathAI: Is pricing published?

No. It is quoted by slide or case volume, pathologist seats and storage, with the clinically cleared configuration priced separately.

Thermo SampleManager LIMS: Can I run it on premise?

Yes. Thermo managed AWS, on premise and customer cloud deployments are all offered.

Share

Related pages

Other head to heads